Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis

13 de novembro de 2026 atualizado por: Elif Umay Altas, Izmir Bakircay University

The Effect of Scapular Mobilization Added to Conventional Exercises on Respiratory Function, Posture, and Quality of Life in Patients With Ankylosing Spondylitis: A Randomized Controlled Trial

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton that commonly leads to restricted spinal mobility, postural deformities such as thoracic hyperkyphosis, and reduced chest wall expansion, which can impair respiratory function and quality of life. Exercise is the cornerstone of rehabilitation in AS, and manual therapy techniques may provide additional benefit by restoring mobility of the thoracic cage and shoulder girdle.

The aim of this randomized controlled, single-blind trial is to investigate whether scapular mobilization added to a conventional exercise program improves chest expansion and respiratory function (primary outcomes), as well as pain, disease activity, function, spinal mobility, posture, exercise capacity, and quality of life (secondary outcomes) in patients with AS. Thirty-four patients will be randomly allocated to either scapular mobilization plus conventional exercise or conventional exercise alone, 3 sessions per week for 8 weeks (24 sessions). Outcomes will be assessed at baseline, after treatment (week 8), and at month 3.

Visão geral do estudo

Descrição detalhada

Background: AS is a chronic inflammatory disease most frequently seen in young men, involving the spine, sacroiliac joints, peripheral joints, and entheses, and causing pain, stiffness, functional impairment, and postural abnormalities. Dysfunction of the thoracic spine and scapular region not only causes pain and limited movement but also restricts chest wall mobility, which may reduce ventilatory efficiency and quality of life. Previous studies have shown that thoracic mobilization exercises improve kyphosis and respiratory function (FVC, FEV1), aerobic exercise improves disease activity and respiratory muscle strength, and manual therapy added to exercise provides superior improvements in chest expansion and functional capacity. However, evidence on the specific added contribution of scapular mobilization to standard exercise programs is limited.

Design: Prospective, randomized, controlled, single-blind, parallel-group trial conducted at the Physical Medicine and Rehabilitation outpatient clinic of Izmir Bakircay University Cigli Training and Research Hospital.

Sample size: Based on Acharya et al. (2024), with an effect size of Cohen's d = 0.40, alpha = 0.05, power = 80%, a two-group repeated-measures design with three time points and a correlation of 0.3 between repeated measures, the minimum sample size is 30 (15 per group). Allowing for a 10% dropout rate, 34 participants (17 per group) will be enrolled.

Interventions: Both groups will receive the same progressive conventional exercise program (30 minutes per session, 3 sessions/week, 8 weeks, 24 sessions), supervised by the same physiotherapist. The experimental group will additionally receive approximately 20 minutes of scapular mobilization per session.

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Progression: Weeks 1-2 (initial level: movement learning, low-intensity mobility, breathing, stretching and low-resistance strengthening; 8-10 repetitions, 1-2 sets, slow tempo); weeks 3-5 (intermediate: increased repetitions and sets, dynamic movements, moderate elastic band resistance, breathing combined with arm movements; 10-15 repetitions, 2-3 sets, moderate tempo); weeks 6-8 (advanced: higher resistance, multi-joint functional movements, dynamic balance and coordination, increased aerobic duration; 12-15 repetitions, 3 sets, moderate-to-high tempo). Progression requires correct form, no increase in pain (VAS) during exercise, return of symptoms to baseline within 24 hours, and improved functional performance. Regression to the previous level occurs with increased pain, prolonged fatigue, postural deterioration, or compensatory movement patterns.

Scapular mobilization: Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Assessments: Demographic and clinical data (age, sex, height, weight, education, occupation, smoking/alcohol, family history, diagnosis year, symptom duration, medications and duration of use, extra-articular involvement, previous surgery, exercise habits) will be recorded. Outcome measures (VAS, BASDAI, BASFI, BASMI, ASQoL, chest expansion, spirometry, 6-minute walk test, thoracic kyphosis angle by digital inclinometer) will be assessed at baseline, after treatment (week 8), and at month 3.

Hypotheses: H0 - Scapular mobilization added to routine exercises has no effect on pain, posture, respiratory function, and quality of life in patients with AS. H1 - Scapular mobilization added to routine exercises has an effect on these parameters.

Statistical analysis: SPSS version 20.0 will be used, with p < 0.05 considered significant. Normality will be tested with the Kolmogorov-Smirnov test. Repeated-measures ANOVA will be used for parametric data; Friedman and Wilcoxon signed-rank tests for non-parametric data. Categorical variables will be compared using the chi-square test.

Tipo de estudo

Intervencional

Inscrição (Estimado)

34

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Izmir, Turquia (Türkiye), 35620
        • Izmir Bakircay University Cigli Training and Research Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

30 anos a 60 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Diagnosis of ankylosing spondylitis according to the modified New York criteria
  • Age between 30 and 60 years
  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of 4.0 or lower
  • Pulmonary function test performed within the last month

Exclusion Criteria:

  • Regular exercise during the previous 3 months
  • Spinal ankylosis
  • Cardiovascular, pulmonary, orthopedic, or neurological conditions that may prevent exercise (uncontrolled hypertension, history of myocardial infarction or coronary revascularization, history of syncope or exercise-related arrhythmia, decompensated type 1 diabetes mellitus, history of hip and/or knee arthroplasty)
  • Any surgery within the last 6 months
  • Active disease flare within the last 3 months
  • Communication problems
  • Any other respiratory or neuromuscular disease that may affect the respiratory muscles

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Scapular Mobilization + Conventional Exercise

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Outros nomes:
  • Maitland scapular mobilization

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Outros nomes:
  • Standard exercise therapy
Comparador Ativo: Conventional Exercise

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Outros nomes:
  • Standard exercise therapy

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Chest Expansion
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Vital Capacity (FVC)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Expiratory Volume in 1 Second (FEV1)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
FEV1/FVC Ratio
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Medidas de resultados secundários

Medida de resultado
Prazo
Peak Expiratory Flow (PEF)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Pain Intensity (Visual Analog Scale)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Disease Activity (BASDAI)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Status (BASFI)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Spinal Mobility (BASMI)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Quality of Life (ASQoL)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Kyphosis Angle
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Exercise Capacity (6-Minute Walk Test)
Prazo: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Elif Umay Altaş, Izmir Bakircay University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

16 de novembro de 2026

Conclusão Primária (Estimado)

16 de novembro de 2027

Conclusão do estudo (Estimado)

25 de novembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

13 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data will not be made publicly available but can be shared with qualified researchers upon reasonable request to the principal investigator.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever